An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisAn Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Sponsor:

Pfizer

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Pfizer on 2024-11-20.